Clinical trial at UB to test new treatment for Parkinson’s disease dementia

Clinical trial at UB to test new treatment for Parkinson’s disease dementia

Publication date: Mar 02, 2019

Clinical trial at UB to test new treatment for Parkinson’s disease dementia One of the challenging characteristics of Parkinson’s disease dementia is ‘imposter syndrome,’ where patients believe that a loved one has been replaced by an identical imposter.

Kinga Szigeti, MD, PhD, Associate professor of neurology and director of the Alzheimer’s Disease and Memory Disorders Center -The neuropsychiatric symptoms can make this kind of dementia much more challenging for families to deal with than Alzheimer’s disease. “

BUFFALO, N. Y. – After Alzheimer’s disease, Lewy body dementia and related Parkinson’s disease dementia (PDD) are some of the most common types of dementia affecting older adults, but they are severely understudied.

Interested patients will be seen at UBMD Neurology, where Szigeti is director of its Alzheimer’s Disease and Memory Disorders Center.

-The neuropsychiatric symptoms can make this kind of dementia much more challenging for families to deal with than Alzheimer’s disease,” Szigeti said.

But now, Western New York patients have an opportunity to participate in the first clinical trial to test a medication for Lewy body dementia at the Jacobs School.

Concepts Keywords
Alzheimer Alzheimer’s disease
Associate Professor Psychiatric diagnosis
Blood Pressure Medicine
Brain Lewy body dementia
Buffalo Parkinson’s disease
Clinical Trial Neuroscience
Clinical Trials Geriatrics
Cognition Parkinsonism
Cognitive RTT
Controlled Drug Psychiatry
Dementia Parkinsons disease
Dopamine Memory Disorders CenterThe
Eli Lilly Kind dementia
Hallucinations Dementia imposter syndrome
Infection Lewy body dementia
Lewy Bodies Psychosis Alzheimers disease
Lewy Body Dementia
Muscle
Nervous System
Neurology
Neurons
Neuropsychiatric
Parkinson
Parkinsonian
PhD
Pipeline
Placebo
Prescribed Medications
Principal Investigator
Psychosis
Rock Hard
Sleep
Stroke
Symptom
Wakefulness

Semantics

Type Source Name
disease MESH dementia
disease DOID dementia
disease MESH syndrome
disease DOID syndrome
gene UNIPROT PDC
disease MESH Memory Disorders
disease MESH Lewy body dementia
disease DOID Lewy body dementia
disease DOID PDD
disease MESH psychosis
disease MESH cognitive decline
disease MESH hallucinations
gene UNIPROT FBN1
disease MESH infection
disease MESH stroke
disease DOID stroke
disease MESH death
drug DRUGBANK Dopamine

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *